Is PCRAF or JNJ a better dividend investment in 2026?

PCRAF currently yields 7181.33% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: PCRAF offers higher current income.

What is the dividend yield difference between PCRAF and JNJ?

PCRAF has a forward dividend yield of 7181.33% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 7177.97 percentage points.

Home › Compare › PCRAF vs JNJ

PCRAF vs JNJ: Dividend Comparison 2026

PCRAF yields 7181.33% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PCRAF wins by $2129323467795842.25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PCRAF

● Live price

7181.33%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2129323467795842.25M

Annual income

$2,072,550,944,745,044,800,000.00

Full PCRAF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — PCRAF vs JNJ

📍 PCRAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PCRAF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PCRAF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PCRAF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRAF

Annual income on $10K today (after 15% tax)

$610,412.93/yr

After 10yr DRIP, annual income (after tax)

$1,761,668,303,033,288,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, PCRAF beats the other by $1,761,668,303,033,288,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRAF + JNJ for your $10,000?

PCRAF: 50%JNJ: 50%

100% JNJ50/50100% PCRAF

Portfolio after 10yr

$1064661733897921.13M

Annual income

$1,036,275,472,372,522,400,000.00/yr

Blended yield

97.33%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCRAF

No analyst data

Altman Z

-16.9

Piotroski

0/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRAF buys

JNJ buys

No recent congressional trades found for PCRAF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPCRAFJNJ

Forward yield	7181.33% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$2129323467795842.25M ✓	$20.0K
Annual income after 10y	$2,072,550,944,745,044,800,000.00 ✓	$827.78
Total dividends collected	$2125520801706147.50M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PCRAF vs JNJ ($10,000, DRIP)

Year	PCRAF Portfolio	PCRAF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$728,833	$718,132.85	$10,676	$355.77	+$718.2K → PCRAF
2	$49,695,629	$48,915,777.42	$11,407	$389.39	+$49.68M → PCRAF
3	$3,170,308,012	$3,117,133,689.10	$12,198	$426.53	+$3170.30M → PCRAF
4	$189,238,958,407	$185,846,728,834.15	$13,056	$467.62	+$189238.95M → PCRAF
5	$10,570,133,462,966	$10,367,647,777,471.07	$13,987	$513.12	+$10570133.45M → PCRAF
6	$552,520,748,327,293	$541,210,705,521,919.44	$14,998	$563.56	+$552520748.31M → PCRAF
7	$27,030,543,997,490,970	$26,439,346,796,780,764.00	$16,098	$619.52	+$27030543997.47M → PCRAF
8	$1,237,774,696,255,956,700	$1,208,852,014,178,641,400.00	$17,295	$681.69	+$1237774696255.94M → PCRAF
9	$53,058,432,757,754,490,000	$51,734,013,832,760,615,000.00	$18,599	$750.82	+$53058432757754.47M → PCRAF
10	$2,129,323,467,795,842,200,000	$2,072,550,944,745,044,800,000.00	$20,022	$827.78	+$2129323467795842.25M → PCRAF

PCRAF vs JNJ: Complete Analysis 2026

PCRAF — Stock

Pucara Gold Ltd. engages in the acquisition, exploration, and evaluation of mineral properties in Peru. The company explores for gold, copper, zinc, lead, and silver deposits. Its project portfolio includes the Lourdes, Pacaska, Capricho, Guadalupe, Keyla, Paco Orco, Pucapaca, and Santo Tomas Projects located in Peru. Pucara Gold Ltd. is based in Vancouver, Canada.

Full PCRAF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this PCRAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRAF vs SCHD PCRAF vs JEPI PCRAF vs O PCRAF vs KO PCRAF vs MAIN PCRAF vs ABBV PCRAF vs MRK PCRAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.